Galderma Group AG (XSWX:GALD) Change In Inventory: CHF-71 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:GALD Galderma Group AG XSWX:GALD
15 GF Score
Price CHF170.65
! 4 Warning Signs
View Full Analysis

What is Galderma Group AG Change In Inventory?

Galderma Group AG XSWX:GALD -1.27% 15 Change In Inventory is CHF-71 Mil as of Dec. 2025. GuruFocus rates XSWX:GALD with a GF Score™ of 15/100. The stock has 4 warning signs investors should review.

Galderma Group AG's change in inventory for the quarter that ended in Dec. 2025 was CHF-18 Mil. It means Galderma Group AG's inventory increased by CHF18 Mil from Jun. 2025 to Dec. 2025 .

Galderma Group AG's change in inventory for the fiscal year that ended in Dec. 2025 was CHF-70 Mil. It means Galderma Group AG's inventory increased by CHF70 Mil from Dec. 2024 to Dec. 2025 .

Galderma Group AG's Total Inventories for the quarter that ended in Dec. 2025 was CHF418 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Galderma Group AG's Days Inventory for the quarter that ended in Dec. 2025 was 108.67.

Inventory Turnover measures how fast the company turns over its inventory within a year. Galderma Group AG's Inventory Turnover for the quarter that ended in Dec. 2025 was 1.68.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Galderma Group AG's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.19.

Galderma Group AG  (XSWX:GALD) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Galderma Group AG's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=413.2995/694.1*365 / 2
=108.67

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Galderma Group AG's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=694.1 / 413.2995
=1.68

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Galderma Group AG's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=413.2995 / 2211.398
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG Change In Inventory Related Terms

Galderma Group AG Change In Inventory Historical Data

* Premium members only.

The historical data trend for Galderma Group AG's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG Change In Inventory Chart

Galderma Group AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
-48.63 -118.69 26.81 -10.70 -70.13

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Change In Inventory Get a 7-Day Free Trial 68.32 -10.73 0.00 -53.67 -17.53
XSWX:GALD
15GF Score
Galderma Group AG XSWX:GALD
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galderma Group AG Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-71 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of CHF-71 Mil mean?
Galderma Group AG (XSWX:GALD) has a Change In Inventory of CHF-71 Mil as of Dec. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Galderma Group AG and its competitors.
Is Galderma Group AG's Change In Inventory too high?
Galderma Group AG's current Change In Inventory is CHF-71 Mil. Overall, Galderma Group AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Galderma Group AG's Change In Inventory compare to ZTS and UTHR?
Galderma Group AG's Change In Inventory of CHF-71 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Galderma Group AG and its competitors. Galderma Group AG's current Change In Inventory is CHF-71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galderma Group AG stock overvalued right now?
Galderma Group AG (XSWX:GALD) has a current Change In Inventory of CHF-71 Mil. The current Change In Inventory is CHF-71 Mil. Galderma Group AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Galderma Group AG (XSWX:GALD), the current Change In Inventory is CHF-71 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galderma Group AG Business Description

Address Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
15GF Score

Get the complete analysis for XSWX:GALD

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF170.65
Price